Moneycontrol PRO
Live Now |Super25 3.0- India’s Largest Online Stock Traders Conference brought to you by Moneycontrol Pro & Espresso

Buy Rossari Biotech; target of Rs 1456: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1456 in its research report dated March 28, 2022.

March 29, 2022 / 03:01 PM IST
The research firm ICICI Securities believes earnings of apparel brands and retail companies under their coverage may surprise positively from Q3FY22E as the likely demand recovery may result in better than expected margin performance. Some of the costs savings achieved during pandemic may sustain and coupled with high operating leverage may lead to higher than pre-covid margins from Q3FY22E.  Stocks like Trent, V-Mart and Aditya Birla Fashion and Retail are the preferred picks backed by their strong and consistent track record of execution.

The research firm ICICI Securities believes earnings of apparel brands and retail companies under their coverage may surprise positively from Q3FY22E as the likely demand recovery may result in better than expected margin performance. Some of the costs savings achieved during pandemic may sustain and coupled with high operating leverage may lead to higher than pre-covid margins from Q3FY22E.  Stocks like Trent, V-Mart and Aditya Birla Fashion and Retail are the preferred picks backed by their strong and consistent track record of execution.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

KR Choksey's research report on Rossari Biotech


We recently visited Dahej plants of ‘Rossari Biotech Ltd (RBL)’ and its subsidiary ‘Unitop Chemicals Ltd’. Both these plants are located within close proximity (in the range of ~4 kms). RBL has two plants located at Silvasa and Dahej with a total manufacturing capacity of 2,52,000 MTPA. The Dahej Plant was fully commissioned in March 2021 as per the planned schedule despite COVID pandemic. Incorporated in 1980, Unitop Chemicals has three manufacturing plants located at Dahej, Patalganga (Maharashtra) and Udhampur (Jammu) with a total capacity of 80,000 MTPA.



Outlook


We have BUY rating on the stock with the target price of INR 1,456/share (an implied PE 35.0x to FY24 EPS).

Close

More Info


At 14:53 hrs Rossari Biotech was quoting at Rs 899.00, down Rs 19.80, or 2.15 percent.


It has touched an intraday high of Rs 930.10 and an intraday low of Rs 896.35.


It was trading with volumes of 15,525 shares, compared to its thirty day average of shares, a decrease of percent.


In the previous trading session, the share closed down 1.27 percent or Rs 11.80 at Rs 918.80.


The share touched its 52-week high Rs 1,620.60 and 52-week low Rs 889.10 on 12 October, 2021 and 07 March, 2022, respectively.


Currently, it is trading 44.53 percent below its 52-week high and 1.11 percent above its 52-week low.


Market capitalisation stands at Rs 4,949.57 crore.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

Broker Research
first published: Mar 29, 2022 03:01 pm
Sections
ISO 27001 - BSI Assurance Mark